2型糖尿病肾病,Type 2 diabetic nephropathy
1)Type 2 diabetic nephropathy2型糖尿病肾病
parison of Two Animal Models of Type 2 Diabetic Nephropathy;两种2型糖尿病肾病动物模型的比较
2.The therapeutic effect of Xuesetong on the urinary microalbumin of type 2 diabetic nephropathy patients;血塞通对2型糖尿病肾病患者尿微量白蛋白的疗效观察
3.Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province;广东汉族人纤溶酶原激活剂抑制物-1基因4G/5G多态性与2型糖尿病肾病的相关性
英文短句/例句
1.Analysis of Related Factors of Diabetic Nephropathy in Type 2 Diabetes;2型糖尿病肾病发病的相关因素分析
2.An experimental rat model of type 2 Diabetic Nephropathy实验性2型糖尿病肾病大鼠模型研究
3.The Correlation Analysis of Smoking and Nephropathy of Type 2 Diabetes Mellitus;吸烟与2型糖尿病肾病的相关性分析
4.Relationship between Paraoxonase 1、Paraoxonase 2 and Apoliplprotein E Gene Polymorphism and Type 2 Diabetic Nephropathy;PON1、PON2、ApoE基因多态性与2型糖尿病肾病
5.Analysis on the risk factors of diabetic nephropathy in older patients with type 2 diabetic mellitus老年2型糖尿病肾病危险因素的分析
6.Application of protein fingerprinting model in diagnosing type 2 diabetic nephropathy应用SELDI-TOF-MS技术诊断2型糖尿病肾病
7.Study of Qidanyishenjiangtang capsule on diabetic nephropathy芪丹益肾降糖胶囊治疗2型糖尿病肾病的研究
8.Changes and Significances of Serum and Urine NGAL in Type 2 Diabetic Nephropathy血尿NGAL在2型糖尿病肾病进展中的变化及意义
9.Clinical Significance and Levels of Urinary ENA-78 in Patients with Type 2 Diabetic Nephropathy2型糖尿病肾病患者尿ENA-78水平的变化及意义
10.Impact of hyperuricemia and insulin resistance on the development of type 2 diabetic nephropathy高尿酸血症对2型糖尿病肾病发展的影响
11.The Relation between Plasma Lipid, HemoglobinAlc and Type 2 Diabetic Nephropathy;糖化血红蛋白及血脂与2型糖尿病肾病的关系
12.Analysis of Clinico-pathological Features and Prognosis in Patients with Type 2 Diabetic Nephropathy;2型糖尿病肾病临床病理特征及预后分析
13.Risk Factors of Diabetic Nephropathy in Patients with Type 2 Diabetes;2型糖尿病患者糖尿病肾病的危险因素分析
parison of pulse pressure in patients of diabetes mellitus with and without diabetic nephropathy2型糖尿病伴或不伴糖尿病肾病的脉压比较
15.Clinical Analysis of IgA Nephropathy and Diabetic Nephropathy in Type 2 Diabetes2型糖尿病合并IgA肾病与糖尿病肾病患者的临床分析
16.The Relationship between Levels of Serum and Urine Midkine and Diabetic Nephropathy in Type2 Diabetes;2型糖尿病患者血清及尿液中期因子与糖尿病肾病的关系
17.The Analysis of the Correlation between C-peptide Level and Morbidity of DN in Diabetes Type Ⅱ;2型糖尿病患者C肽水平与糖尿病肾病发病率相关性分析
18.Investigation in Renal Function of 168 Patients with Type 2 Diabetes Mellitus;168例2型糖尿病患者肾功能调查
相关短句/例句
Diabetic nephropathy2型糖尿病肾病
1.Relationship between Th1/Th2 lymphocyte imbalance in peripheral blood and type 2 diabetic nephropathy;外周血Th1/Th2淋巴细胞失衡与2型糖尿病肾病的关系
2.Effect of Serum Levels of Advanced Glycation Endproducts on Diabetic Nephropathy;研究血清AGEs水平在2型糖尿病肾病中的作用
3.To study the clinical characteristic of type 2 diabetic nephropathy .目的： 一、探讨2型糖尿病肾病患者临床特征； 二、探讨纤溶酶原激活剂抑制物-1(PAI-1)基因4G/5G多态性与广东汉族糖尿病肾病的相关性。
3)type 2 diabetes nephropathy2型糖尿病肾病
1.[Objective] To determine the levels of serum homocysteine(HCY) in type 2 diabetes(T2DM),and find the difference of levels of HCY among each stage oftype 2 diabetes nephropathy(T2DN) so that we can find whether HCY can play an important role on the early finding of T2DN.[结论]高同型半胱氨酸浓度是2型糖尿病肾病的一个独立危险因素,测定糖尿病患者血清HCY水平有助于判断和监测2型糖尿病肾病的发生和发展,血清HCY水平随着UAER的增加而升高。
4)2-DN2-型糖尿病肾病
1.Objective To develop a indirect ELISA method for the detection of plasma anti-CA IV antibody and to evaluate the relationship between anti-CA IV antibody with pathogenesis of NS, CGN and2-DN.目的建立使用间接酶联免疫吸附法(ELISA)检测人血浆抗碳酸酐酶IV抗体的方法,阐明血浆抗碳酸酐酶IV抗体滴度与肾病综征合(NS)、慢性肾小球肾炎(CGN)和2-型糖尿病肾病(2-DN)三种肾脏病的联系。
5)type 2 diabetes and early signs of nephropathy2型糖尿病早期肾病
1.Objective To observe the efficacy and safety of Xingding Injection plus irbesartan in treating the patients withtype 2 diabetes and early signs of nephropathy.目的观察杏丁注射液联合厄贝沙坦治疗2型糖尿病早期肾病的疗效。
6)Senile type2diabetic nephropathy老年2型糖尿病肾病
延伸阅读
糖尿病性肾病糖尿病性肾病diabetic nephropahy糖尿病时常合并有糖尿病性肾小球硬化症、肾盂肾炎及肾乳头坏死，小动脉性肾硬化等肾病。但糖尿病性肾病，通常是指与糖代谢异常有关的糖尿和肾小球硬化症。它是糖尿病全身性微血管病变的一部分，发病与遗传因素及糖代谢异常有关。糖尿病与血管病变均属遗传缺陷结果，在高血糖导致肾小球高滤过的条件下，与肾某种转换酶的作用下，使肾小球基底膜糖蛋白合成增加并沉积，引起基膜增厚和通透性改变，系膜内基膜样物质增加。于是临床出现蛋白尿、肾病综合征、高血压以及肾功能不全。近年研究糖尿病肾病要历经间歇性微白蛋白尿期、持续性微白蛋白尿期、临床蛋白尿期及肾功能不全四期。一般认为从糖尿病发病至临床蛋白尿期约有10～，尔后再经4～进入尿毒症期。本病按其病理损害特征，可分为结节型及弥漫型两型，但两型往往同时并存。据研究在微白蛋白期积极控制糖尿病，肾病可望逆转，至临床蛋白尿期仅能延缓肾病的进展或恶化。在发生尿毒症后应考虑透析疗法或肾移植。
